Capecitabine and Oxaliplatin Prior and Concurrent to Preoperative Pelvic Radiotherapy in Patients With Locally Advanced Rectal Cancer: A Survival Analysis.
N/A
18 Years
N/A
18 Years
N/A
Not Enrolling
Both
Colorectal Cancer
Both
Colorectal Cancer
Trial Information
Capecitabine and Oxaliplatin Prior and Concurrent to Preoperative Pelvic Radiotherapy in Patients With Locally Advanced Rectal Cancer: A Survival Analysis.
Inclusion Criteria:
- Patients who took part in and concluded study ML18280 according to protocol
Exclusion Criteria:
- N/A
Type of Study:
Observational
Study Design:
Observational Model: Cohort, Time Perspective: Retrospective
Outcome Measure:
Progression-free survival, defined as time from first administration of study medication in study ML18280 to disease progression or death of any cause
Outcome Time Frame:
up to 5 years
Safety Issue:
No
Principal Investigator
Clinical Trials
Investigator Role:
Study Director
Investigator Affiliation:
Hoffmann-La Roche
Authority:
Switzerland: Swissmedic
Study ID:
ML21875
NCT ID:
NCT01339832
Start Date:
August 2010
Completion Date:
December 2011
Related Keywords:
- Colorectal Cancer
- Rectal Neoplasms
- Colorectal Neoplasms
Name | Location |
|---|
